Journal of Biological Chemistry · 2019 · 87 citations · 60 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologySignal TransductionBreast Cancer PharmacotherapyEnzyme InhibitionGlutamine Synthetase InhibitionPharmacodynamics Of Anticancer AgentsTriple-negative Breast Cancer Therapy
) gene expression. Of note, CB-839-resistant TNBC cells had increased carnitine palmitoyltransferase 2 (CPT2) protein and CPT1 activity levels. In agreement, CB-839-resistant TNBC cells mobilized more fatty acids into mitochondria for oxidation, which responded to AMP-activated protein kinase and acetyl-CoA carboxylase signaling. Moreover, chemical inhibition of both glutaminase and CPT1 decreased cell proliferation and migration of CB-839-resistant cells compared with single inhibition of each enzyme. We propose that dual targeting of glutaminase and CPT1 activities may have therapeutic relevance for managing CB-839-resistant tumors.
60
Gene Ontology: tool for the unification of biology
Michael Ashburner, Catherine A. Ball, Judith A. Blake et al. · Nature Genetics · 2000 · 44.6K citations · Full text
Gene ontology analysis for RNA-seq: accounting for selection bias
Matthew D. Young, Matthew J. Wakefield, Gordon K. Smyth et al. · Genome biology · 2010 · 7.8K citations · Full text